Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder

Table 2 Information on immunosuppressive treatments, sampling date, last relapse date, relapse status, and EDSS score of NMOSD and MS patients

Patient number	Disease	Age	Sex	Treatment	Days passed from onset to sampling date (d)	Disease duration (m)	Relapse or stable	EDSS score
1	NMOSD	35	F	MMF	60	90	Stable	2
2	NMOSD	36	F	MFF	850	72	Stable	1.5
3	NMOSD	41	F	PD	197	6	Stable	3.5
4	NMOSD	33	M	MMF	1767	216	Stable	4
5	NMOSD	30	F	MMF	565	139	Stable	1.5
6	NMOSD	39	M	MMF	203	111	Stable	7.5
7	NMOSD	44	F	AZA	63	8	Stable	0
8	NMOSD	28	F	RTX	282	130	Stable	1
9	NMOSD	36	F	PD	79	7	Stable	2
10	NMOSD	30	F	MMF	834	64	Stable	2
11	NMOSD	50	F	AZA	418	13	Stable	5
12	NMOSD	36	F	MMF	1783	266	Stable	2
13	NMOSD	46	M	RTX	69	15	Stable	3
14	NMOSD	32	F	AZA	475	113	Stable	2
15	NMOSD	40	F	MMF	799	235	Stable	3
16	NMOSD	34	F	PD	60	7	Stable	2.5
17	NMOSD	31	F	MMF	817	49	Stable	2
18	NMOSD	29	F	MMF	1403	50	Stable	1.5
19	NMOSD	46	F	RTX	1753	206	Stable	2
20	NMOSD	33	M	RTX	64	245	Stable	2.5
21	MS	42	F	Glatiramer acetate	71	78	Stable	3.5
22	MS	38	F	Teriflunomide	87	84	Stable	4
23	MS	30	M	Naïve	113	77	Stable	3
24	MS	27	F	Interferon-β	904	85	Stable	5
25	MS	35	F	Interferon-β	2014	161	Stable	4
26	MS	19	M	Glatiramer acetate	208	29	Stable	2
27	MS	25	M	Naïve	60	3	Stable	2
28	MS	23	F	Interferon-β	405	13	Stable	3.5
29	MS	23	F	Glatiramer acetate	424	13	Stable	2
30	MS	46	F	Interferon-β	1888	76	Stable	0
31	MS	33	F	Naïve	60	31	Stable	2.5
32	MS	31	F	Interferon-β	284	18	Stable	2.5
33	MS	51	F	Interferon-β	872	121	Stable	2.5
34	MS	34	F	Interferon-β	739	35	Stable	0
35	MS	34	M	Interferon-β	225	25	Stable	2
36	MS	26	F	Interferon-β	206	40	Stable	0
37	MS	44	F	Interferon-β	191	10	Stable	0
38	MS	36	F	Interferon-β	1508	151	Stable	1.5
39	MS	36	F	Interferon-β	519	43	Stable	3.5
40	MS	34	F	Interferon-β	840	115	Stable	2

ISSN: 1742-2094